According to Kyverna Therapeutics's latest financial reports the company's current revenue (TTM) is $7.02 M. In 2022 the company made a revenue of $7.02 M an increase over the years 2021 revenue that were of $5.65 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.28 M | -95.99% |
2022 | $7.02 M | 24.2% |
2021 | $5.65 M |